The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Sorafenib as second-line treatment in metastatic renal cell carcinoma: A prospective cohort.

Ana Elena  Martin Aguilar

Speakers' Bureau - Bayer; Bristol-Myers Squibb (Mexico); Ipsen; Pfizer

Travel, Accommodations, Expenses - Bayer; Pfizer

Haidé Nayeli  Núñez-López

Travel, Accommodations, Expenses - Bristol-Myers Squibb

Juan C. Carlos  Ramirez-Sandoval

Honoraria - Amgen; Mercurio S.A. de C.V.; Roche; Takeda

Consulting or Advisory Role - Takeda

Research Funding - Laboratorios Valdecasas